Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
In furtherance to our intimation dated October
28, 2023, on the inspection conducted by the United States Food & Drug Administration (USFDA) at the Company's formulations
manufacturing facility (FTO-3) in Bachupally, Hyderabad, we wish to inform you that the Company has received the Establishment Inspection
Report (EIR). The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is "closed"
under 21 CFR 20.64(d)(3).
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer and Head-CSR